We are live on
!
Find out more
Calamos Advisors Portfolio holdings
AUM
$30.1B
1-Year Est. Return
30.03%
This Fund
S&P 500
This Quarter
Est. Return
+0.09%
1 Year Est. Return
+30.03%
3 Year Est. Return
+88.6%
5 Year Est. Return
+115.14%
10 Year Est. Return
+349.12%
AUM
$15.4B
AUM Growth
-$4.25B
(-22%)
Cap. Flow
-$11.2B
Cap. Flow
% of AUM
-72.83%
Top 10 Holdings %
Top 10 Hldgs %
18.29%
Holding
643
New
38
Increased
264
Reduced
90
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$129M |
| 2 |
American International
AIG
|
+$82.2M |
| 3 |
AGN
Allergan plc
AGN
|
+$80.4M |
| 4 |
Meta Platforms (Facebook)
META
|
+$74.9M |
| 5 |
Humana
HUM
|
+$67.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN.PRA
Allergan plc
AGN.PRA
|
+$92.5M |
| 2 |
Wells Fargo
WFC
|
+$55.4M |
| 3 |
AMT.PRB
American Tower Corporation
AMT.PRB
|
+$50.1M |
| 4 |
Apple
AAPL
|
+$48.6M |
| 5 |
ZEN
ZENDESK INC
ZEN
|
+$36.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 11.23% |
| 2 | Technology | 9.26% |
| 3 | Healthcare | 8.87% |
| 4 | Communication Services | 6.39% |
| 5 | Consumer Discretionary | 6.26% |
Similar funds
Calamos Advisors's Q1 2018 Portfolio in Review
As of Q1 2018, Calamos Advisors held 643 positions worth $15.4B, down 22% from $19.6B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Calamos Advisors withdrew a net $11.2B in Q1 2018, closing 44 positions and reducing 90 holdings. Its most notable exit was Allergan plc, an estimated $92.5M position sold in full.
By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.5% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Calamos Advisors opened a new position in Humana worth $67.1M.
- Calamos Advisors's largest Q1 2018 buy was Humana: 249,674 shares worth $67.1M.
- Calamos Advisors added most to State Street SPDR S&P 500 ETF Trust in Q1 2018, an estimated $129M increase.
- Calamos Advisors's biggest Q1 2018 reduction was Wells Fargo, cutting an estimated $55.4M.
- Calamos Advisors fully exited Allergan plc in Q1 2018, selling an estimated $92.5M.
- Calamos Advisors's ten largest holdings make up 18% of its $15.4B portfolio in Q1 2018.
- Calamos Advisors opened 38 new positions and closed 44 in Q1 2018.
- Calamos Advisors's portfolio value fell 22% quarter-over-quarter to $15.4B.
Based on Calamos Advisors's 13F filing for Q1 2018, filed 13 Apr 2018.